Biotech short seller eviscerates Proteostasis in new report, dinging shares
March 20, 2018 at 11:41 AM EDT
Kerrisdale Capital Management and its founder, Sahm Adrangi, have earned a reputation for publicly shaming biotechs in the past, including at least two other firms based in Massachusetts.
